Clinical safety becomes part of supplier assurance
A safe product doesn’t guarantee a safe deployment. Assurance has to follow the manufacturer’s safety evidence into local configuration, integration and workflow.
Rules: DCB0129 and DCB0160 (England), DTAC.
How we help: Assess, with testing that follows the evidence into deployment.
Critical suppliers come into scope
The supplier that matters most isn’t always the biggest contract. It’s the one whose failure would stop a clinical service and couldn’t be replaced quickly, as the 2024 attack on a London pathology provider showed.
Rules: the NIS Regulations, NIS2 in the EU, and the proposed Cyber Security and Resilience Bill.
How we help: Define for tiering by consequence, Oversee for concentration risk.
Medical devices outlive their software
A device can stay in clinical use long after a component, cloud service or support route behind it has reached end of life.
Rules: UK and EU post-market surveillance, EU MDR cybersecurity guidance.
AI assurance continues after go-live
An AI tool approved at procurement may not be the same tool a year later. Changes to the model, data or workflow need to be tracked and reassessed.
Rules: the EU AI Act, and the UK government’s response to the commission on AI in healthcare.
Health data has to move safely between suppliers
Owning your data isn’t the same as being able to move it, complete and with its clinical meaning intact, when you change supplier.
Rules: the European Health Data Space, UK GDPR.
How we help: Define, with contract, exit and data-portability standards.